Eva Szabo

A Phase I Study of myo-Inositol for Lung Cancer Chemoprevention

Calum MacAulay, Annette McWilliams, Stephen Lam, 2006, Cancer Epidemiology Biomarkers & Prevention.

Transforming Cancer Prevention through Precision Medicine and Immune-oncology

Avrum Spira, J Jack Lee, Zigang Dong, 2016, Cancer Prevention Research.

MUC1 expression in lung cancer.

Eva Szabo, 2003, Methods in molecular medicine.

Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited

M. Melamed, P. Prorok, M. Tockman, 2009, Cancer.

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.

Udayan Guha, Seth M Steinberg, Keith Killian, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

AACR Cancer Progress Report 2015

Nina Bhardwaj, Ronald P. DeMatteo, William C. Hahn, 2015, Clinical Cancer Research.

Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening

Paul Pinsky, P. Pinsky, E. Szabo, 2018, Chest.

Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668

Rui Qin, Brent A Bauer, Sumithra J Mandrekar, 2011, Cancer Prevention Research.